(News Bulletin 247) – While adjusting its price target from 85 to 86 euros, Stifel reiterates its ‘hold’ recommendation on Equasens, showing a preference for its peers Nexus and CompuGroup, both recommended ‘buy’, in the sector health informatics.
‘Equasens unveiled a solid turnover for the first quarter, with organic growth reaching 14% (+11.1% excluding the Segur digitization plan in France)’, he highlights after the point of activity.
The broker raises its organic growth assumption for 2023 from 6.1% to 6.4%, but ‘remains cautious as activity can be bumpy, and the bases of comparison will become increasingly difficult This year’.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
